Clinical diagnosis, monitoring and biomarkers in ILDs
M. Kreuter (Heidelberg, Germany)
|     |
Radiologic evaluation of ILDs
C.P. Heussel (Heidelberg, Germany)
| |
Pathology of ILDs
A. Warth (Heidelberg, Germany)
| |
Bronchoscopic and surgical diagnostic procedures in ILDs
F. Herth (Heidelberg, Germany)
| |
Idiopathic pulmonary fibrosis (IPF)
J. Behr (Munich, Germany)
| |
Non-IPF idiopathic interstitial pneumonia (IIPs)
T. Maher (London, United Kingdom)
| |
Combined pulmonary fibrosis and emphysema syndrome, DIP and RB-ILD
V. Cottin (Lyon, France)
| |
Sarcoidosis and berylliosis
T. Geiser (Bern, Switzerland)
| |
Hypersensitivity pneumonitis
M. Vasakova (Prague, Czech Republic)
| |
Paediatric interstitial lung disease
E. Eber (Graz, Austria)
| |
Occupational and drug-induced ILDs
W. Wuyts (Leuven, Belgium)
| |
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
B. Crestani (Paris, France)
| |
Connective tissue disease-associated lung disease
M. Kreuter (Heidelberg, Germany)
| |
Pulmonary vasculitis
T. Maher (London, United Kingdom)
| |
Pulmonary hypertension and cardiovascular diseases in ILD
V. Cottin (Lyon, France)
| |
Genetics of ILD
B. Crestani (Paris, France)
| |
Pathogenesis of ILD
O. Eickelberg (Munich, Germany)
| |
Cell therapy in ILD
T. Geiser (Bern, Switzerland)
| |
Future treatment modalities
W. Wuyts (Leuven, Belgium)
| |
Future developments in IPF biomarkers
O. Eickelberg (Munich, Germany)
| |
Lung cancer in ILD
F. Herth (Heidelberg, Germany), N. Kahn (Heidelberg, Germany)
| |
GERD in ILDs
M. Kreuter (Heidelberg, Germany)
| |
The role of ILD nurses & patient support groups: optimising care for ILD
A.M. Russell (London, United Kingdom)
| |
Pulmonary rehabilitation
T. Geiser (Bern, Switzerland)
| |
Managing end stage disease in ILDs
M. Vasakova (Prague, Czech Republic)
| |
Lung transplantation
J. Egan (Dublin, Ireland), P. Riddell (Dublin, Ireland)
| |